Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-22

Clinical Trial Update: Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD [Phase 4]

View source ↗

Summary

This Phase 4 study completed by Pfizer compared atorvastatin with simvastatin for the prevention of coronary heart disease in patients with known coronary heart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipitor (atorvastatin)
  • Zocor (simvastatin)

Snippet

Sponsor: Pfizer | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED